Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
for
Huntington Disease
Location: Montreal, Burlington VT, Albany NY, Boston MA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 21 - 70
Code: NCT07326709
Phase3, Recruiting
Active & Responsive
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
for
Friedreich Ataxia
Location: Montreal, Toronto, Philadelphia PA, Columbus OH,
Sponsor: Friedreich's Ataxia Research Alliance
Sex: All
Age: 0+
Code: NCT06016946
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Montreal, Levis, Boston MA, Providence RI, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Montreal, Ottawa, Syracuse NY, Toronto, Neptune City NJ,
Sponsor: University of Texas Southwestern Medical Center
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT06743581
Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Montreal, Kingston, Albany NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for
Malignant Neoplasm
Location: Montreal, Quebec, Toronto, New Brunswick NJ, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07247110
Phase1, Recruiting
Active & Responsive
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
for
Breast Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: Female
Age: 18+
Code: NCT06222788
Recruiting
Active & Responsive
Clinical Course Of Disease In Participants With FA-CM
for
Friedreich Ataxia, Cardiomyopathy
Location: Montreal, Boston MA, Cincinnati OH, Indianapolis IN,
Sponsor: Lexeo Therapeutics
Sex: All
Age: 6+
Code: NCT06865482
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease